Free Trial

Bionano Genomics (BNGO) News Today

Bionano Genomics logo
$5.36 +0.02 (+0.37%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$5.28 -0.08 (-1.49%)
As of 02/21/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Bionano Genomics, Inc. stock logo
Bionano Genomics, Inc. (NASDAQ:BNGO) Short Interest Update
Bionano Genomics, Inc. (NASDAQ:BNGO - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 341,500 shares, a decline of 98.1% from the December 31st total of 17,650,000 shares. Approximately 14.7% of the shares of the company are short sold. Based on an average trading volume of 143,900 shares, the short-interest ratio is presently 2.4 days.
Bionano Genomics, Inc. stock logo
Bionano Genomics (NASDAQ:BNGO) Trading Up 5.5% - Still a Buy?
Bionano Genomics (NASDAQ:BNGO) Trading Up 5.5% - Here's What Happened
Bionano Genomics, Inc. stock logo
Bionano Genomics (NASDAQ:BNGO) Shares Gap Down - Here's Why
Bionano Genomics (NASDAQ:BNGO) Shares Gap Down - Here's Why
Bionano Genomics, Inc. stock logo
Bionano Genomics (NASDAQ:BNGO) Sets New 12-Month Low - Here's What Happened
Bionano Genomics (NASDAQ:BNGO) Sets New 1-Year Low - Time to Sell?
Bionano Genomics trading halted, news pending
Bionano Announces Effective Date of Reverse Stock Split
Bionano Genomics announces use of OGM in preimplantation genetic testing
Bionano Genomics announces publication on OGM for AML
Bionano sells 39.68M shares at 25.2c in registered direct offering
Bionano Genomics announces publication in Modern Pathology on OGM
Bionano Genomics announces presentations at ASH annual meeting
Ladenburg downgrades Bionano Genomics on restructuring uncertainty
Scotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)
Bionano Genomics Sees Growth in OGM Adoption
Bionano Genomics reports Q3 revenue $6.1M, consensus $7.85M.
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript
Bionano Genomics announces publication outlining utility of OGM
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
BTIG downgrades BioNano Genomics (BNGO) to a Hold
BTIG Downgrades Bionano Genomics (BNGO)
Get Bionano Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter.

BNGO Media Mentions By Week

BNGO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BNGO
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

BNGO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BNGO Articles
This Week

0

2

BNGO Articles
Average Week

Get Bionano Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BNGO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners